PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS
Last updated: 03 Jan 2025
10.21608/ajps.2023.332167
Pyridine derivative, Anti-cancer agents, Biological targets
Mohamed Ayman
El-Zahabi
ALy
Al Mockhaim Al Daem street, Nasr 6thdistrict, Cairo Egypt
malzahaby@azhar.edu.eg
Nasr
0000-0003-4538-5840
Reda
Yousef
G
Department of Pharmaceutical Medicinal Chemistry & Drug Design, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo11884, Egypt.
Ibrahim
Eissa
H
Department of Pharmaceutical Medicinal Chemistry & Drug Design, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo11884, Egypt.
Alaa
Elwan
Department of Pharmaceutical Medicinal Chemistry & Drug Design, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo11884, Egypt.
68
2
44970
2023-09-01
2023-12-25
2023-09-01
64
81
1110-1644
2535-1958
https://ajps.journals.ekb.eg/article_332167.html
https://ajps.journals.ekb.eg/service?article_code=332167
332,167
Journal
Al-Azhar Journal of Pharmaceutical Sciences
https://ajps.journals.ekb.eg/
PYRIDINE DERIVATIVES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS
Details
Type
Article
Created At
23 Dec 2024